Should You Buy Haemonetics Corp (HAE) Today? Analysis, Price Targets, and 2026 Outlook.
No data
No data
Growth
Profitability
Efficiency
Wall Street analysts forecast HAE stock price to rise
8 Analyst Rating
Wall Street analysts forecast HAE stock price to rise
4 Buy
4 Hold
0 Sell
Moderate Buy
Current: 67.040
Low
74
Averages
88.86
High
99
Current: 67.040
Low
74
Averages
88.86
High
99
Citi
Neutral
maintain
$64 -> $70
AI Analysis
2026-05-28
New
Reason
Citi
Price Target
$64 -> $70
AI Analysis
2026-05-28
New
maintain
Neutral
Reason
Citi raised the firm's price target on Haemonetics to $70 from $64 and keeps a Neutral rating on the shares. The firm updated models in the medical technology space post the Q1 reports. Citi believes fundamentals in the sector remain solid.
Barrington
Outperform
downgrade
$94 -> $89
2026-05-12
Reason
Barrington
Price Target
$94 -> $89
2026-05-12
downgrade
Outperform
Reason
Barrington lowered the firm's price target on Haemonetics to $89 from $94 and keeps an Outperform rating on the shares citing somewhat lower profitability expectations for FY27 based on the company's initial guidance.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for HAE
